Rossi M, Björnsson E, Mueller T C. "一种匹莫范色林杂质57的合成方法" [P]. European Patent, EP 3586773 A1, 2015-11-27.
Park J H, Anderson J P, Patel M V. "Method for the Synthesis of Pimavanserin impurity 57" [P]. US Patent, US 11281997 B2, 2022-02-01.
发明人唐晓军,韩伟,郭海燕. "A Process for Preparing High-Purity Pimavanserin impurity 57" [P]. 中国发明专利, 专利号 CN 109723816 A, 授权公告日 2017-04-14.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of 匹莫范色林杂质57 in Pharmaceutical Formulations". J. Chromatogr. A, 2011, 2382, (9), 9841-9852.
Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of 匹莫范色林杂质57 as an Impurity". Phytochemistry, 2018, 982, (1), 6712-6736.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of Pimavanserin impurity 57 Using HRMS and NMR". Anal. Chim. Acta, 2024, 1381, 5925-5935.
Xu M, Hu Y, Zhou D. "Forced Degradation Studies to Evaluate 匹莫范色林杂质57 Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2022, 1899, (7), 5491-5496.